40 mg of Aspirin Are Not Sufficient to Inhibit Platelet Function under Conditions of Limited Compliance
- 1 March 2000
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 97 (5) , 365-367
- https://doi.org/10.1016/s0049-3848(99)00171-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Aspirin and Platelets: The Antiplatelet Action of Aspirin and Its Role in Thrombosis Treatment and ProphylaxisSeminars in Thrombosis and Hemostasis, 1997
- Major depression and medication adherence in elderly patients with coronary artery disease.Health Psychology, 1995
- Aspirin as an Antiplatelet DrugNew England Journal of Medicine, 1994
- Incomplete Inhibition of Platelet Secretion by Low-dose AspirinPlatelets, 1994
- Direct inhibition of platelet function by organic nitrates via nitric oxide formationEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and backTrends in Pharmacological Sciences, 1989
- Blood-vessel wall arachidonate metabolism and its pharmacological modification in a new in vitro assay systemNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
- Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugsBlood, 1987
- Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy SubjectsJournal of Clinical Investigation, 1982